Get access to more insightful information
By signing up to Upstox today
DSP Healthcare Fund Direct growth
Equity • Healthcare • Direct growth
Insufficient fund history to generate its report card
Fund Info
Equity
Healthcare
Direct growth
Launched On
30 Nov 2018
6.3 years ago
Lock-in Period
No lock-in
NAV
as of 27 Mar 2025
₹41.09
+0.134% (0.10)
AUM
₹3,198 Cr
Expense ratio
0.63%
Benchmark
Fund Plan
Tax info and exit load
Taxes
Units held less than 1Y
20.00%
Units held more than 1Y
12.50%
Exit Load
If units sold before 1M
0.5%
If units sold after 1M
0%
What's in this fund?
Sectors
Holdings
Healthcare
Financial Services
Fund Managers
Chirag Dagli
Experience: 4.31 yrs • Total AUM: 30,581 Cr
CAGR
₹1,000 invested for 5 years
Distribution
Market capital
Fund House
DSP
Inc: 29 Apr 1997 • Total AUM: ₹1,70,117 Cr • Rank #9DSP Mutual Fund started in 1996 has DSP Asset Managers Pvt ltd as its sponsors. The fund house is headed by Kalpen Parekh as the CEO. As of 30 Sep 2022, it has an AUM of 111158.08 crores
Risk
Category risk
Very high
As provided by the fund house document, this risk is specific to this fund category (Equity). To know the risk of this fund particularly, check 'Risk vs Category'.
Other top rated funds
SBI Healthcare Opportunities Fund
Equity • Healthcare • Direct Growth3Y CAGR
24.43%
Expense ratio
0.97%
Returns vs category
N/A
Risk vs category
N/A
ICICI Prudential Pharma Healthcare and Diagno...
Equity • Healthcare • Direct Growth3Y CAGR
24.02%
Expense ratio
1.11%
Returns vs category
N/A
Risk vs category
N/A
ITI Pharma and Healthcare Fund
Equity • Healthcare • Direct Growth3Y CAGR
20.65%
Expense ratio
0.47%
Returns vs category
N/A
Risk vs category
N/A
UTI Healthcare Fund
Equity • Healthcare • Direct Growth3Y CAGR
20.60%
Expense ratio
1.23%
Returns vs category
N/A
Risk vs category
N/A
Tata India Pharma & Healthcare Fund
Equity • Healthcare • Direct Growth3Y CAGR
20.39%
Expense ratio
0.74%
Returns vs category
N/A
Risk vs category
N/A
Disclaimer: Top rated funds do not constitute any advice. Research data is powered by Morningstar. Please read the offer documents carefully before investing. Upstox shall not accept any liability arising out of your investments.